ISIN | CH0461413939 |
---|---|
Valor Number | 46141393 |
Bloomberg Global ID | |
Fund Name | Swisscanto (CH) Index Equity Fund United Kingdom NT GBP |
Fund Provider |
Swisscanto Fondsleitung AG
Zurich E-Mail: fonds@swisscanto.ch |
Fund Provider | Swisscanto Fondsleitung AG |
Representative in Switzerland | |
Distributor(s) | Schweizerische Kantonalbanken |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | The fund charges a transaction fee (contribution towards covering expenses incurred in the sale of assets) |
Investment Strategy *** | Die Anlagen dieses Teilvermögens erfolgen in Anlehnung an den MSCI® United Kingdom Index, welcher von der MORGAN STANLEY CAPITAL INTERNATIONAL INC. (MSCI) fest-gelegt und berechnet wird und darauf ausgelegt ist, die Performance der Mid- und Large Cap Segmente des Marktes des Vereinigten Königreiches (Grossbritannien und Nordirland) zu messen. |
Peculiarities |
Current Price * | 143.78 GBP | 20.05.2025 |
---|---|---|
Previous Price * | 142.45 GBP | 19.05.2025 |
52 Week High * | 143.78 GBP | 20.05.2025 |
52 Week Low * | 125.28 GBP | 09.04.2025 |
NAV * | 143.78 GBP | 20.05.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 135,388,494 | |
Unit/Share Assets *** | 121,321,708 | |
Trading Information SIX |
YTD Performance | +9.21% |
31.12.2024 - 20.05.2025
31.12.2024 20.05.2025 |
---|---|---|
YTD Performance (in CHF) | +6.63% |
31.12.2024 - 20.05.2025
31.12.2024 20.05.2025 |
1 month | +5.55% |
22.04.2025 - 20.05.2025
22.04.2025 20.05.2025 |
3 months | +2.74% |
20.02.2025 - 20.05.2025
20.02.2025 20.05.2025 |
6 months | +10.50% |
20.11.2024 - 20.05.2025
20.11.2024 20.05.2025 |
1 year | +7.77% |
21.05.2024 - 20.05.2025
21.05.2024 20.05.2025 |
2 years | +21.56% |
22.05.2023 - 20.05.2025
22.05.2023 20.05.2025 |
3 years | +32.24% |
20.05.2022 - 20.05.2025
20.05.2022 20.05.2025 |
5 years | +76.81% |
20.05.2020 - 20.05.2025
20.05.2020 20.05.2025 |
Equity Participation Rate in % | 97.98 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
AstraZeneca PLC | 8.37% | |
---|---|---|
Shell PLC | 7.48% | |
HSBC Holdings PLC | 7.48% | |
Unilever PLC | 5.93% | |
RELX PLC | 3.80% | |
British American Tobacco PLC | 3.25% | |
Rolls-Royce Holdings PLC | 3.23% | |
GSK PLC | 3.09% | |
BP PLC | 2.84% | |
London Stock Exchange Group PLC | 2.79% | |
Last data update | 30.04.2025 |
TER | 0.00% |
---|---|
TER date | 30.09.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | |
Ongoing Charges *** | 0.00% |
SRRI ***
|
|
SRRI date *** | 30.04.2025 |